YAP regulates PD-L1 expression in human NSCLC cells. Read more about YAP regulates PD-L1 expression in human NSCLC cells.
Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma. Read more about Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.
Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer. Read more about Stromal Annexin A2 expression is predictive of decreased survival in pancreatic cancer.
Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma. Read more about Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma.
Host histone acetylation unlocks HDAC inhibitor potential. Read more about Host histone acetylation unlocks HDAC inhibitor potential.
Two new species of betatorqueviruses identified in a human melanoma that metastasized to the brain. Read more about Two new species of betatorqueviruses identified in a human melanoma that metastasized to the brain.
Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma. Read more about Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma.
Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer. Read more about Membrane-bound full-length Sonic Hedgehog identifies cancer stem cells in human non-small cell lung cancer.
Peroxiredoxin 3 maintains the survival of endometrial cancer stem cells by regulating oxidative stress. Read more about Peroxiredoxin 3 maintains the survival of endometrial cancer stem cells by regulating oxidative stress.
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy. Read more about Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.
